CNTB - CIK 0001835268
Connect Biopharma Holdings Ltd trades as CNTB. In its fiscal 2025 annual report the company posted revenue of $64.00K, down 99.8% from the prior year and net income of -$55.48M. This page tracks Connect Biopharma Holdings Ltd through 180 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| F-3 | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-12 |
| Major company event | 8-K | 2026-05-12 |
| Major company event | 8-K | 2026-04-23 |
| SCHEDULE 13G | - | 2026-04-14 |
| Insider trade | 4 | 2026-04-02 |
| Insider trade | 4 | 2026-04-02 |
The largest companies sharing Connect Biopharma Holdings Ltd's SEC industry classification (pharmaceutical preparations).
Connect Biopharma Holdings Ltd reported revenue of $64.00K for fiscal year 2025, a decrease of 99.8% year over year.
In its latest fiscal year Connect Biopharma Holdings Ltd reported a net loss of $55.48M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.